CALGARY, Alberta, May 07, 2024 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) ("Enerflex" or the "Company"), announces that at its Annual Meeting of Shareholders (the "Meeting") held virtually on May 7, 2024, Enerflex’s shareholders approved the election of all 10 nominee directors presented in the Company’s Management Information Circular dated March 15, 2024. The shares represented at the Meeting voting on individual nominee directors were as follows:  ApprovalAgainstDirectorVotes ForPercentageVotes AgainstPercentageFernando Assing77,625,39291.3%7,416,5068.7%Joanne Cox73,577,70886.5%11,464,19013.5%Byron Dunn57,993,00468.2%27,048,89431.8%James Gouin76,193,51489.6%8,848,38410.4%Mona Hale71,755,09584.4%13,286,80315.6%Kevin Reinhart59,399,21569.9%25,642,68330.1%Marc Rossiter70,443,11982.8%14,598,77917.2%Thomas Tyree84,117,82498.9%924,0741.1%Juan Carlos Villegas72,735,77885.5%12,306,12014.5%Michael Weill67,978,89279.9%17,063,00620.1%  At the Meeting, shareholders also approved the re-appointment of Ernst & ...

VANCOUVER, BC, May 8, 2024 /CNW/ - NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is pleased to announce that it has entered into a binding term sheet with MMCap International Inc. SPC ("MMCap") for the purchase (the "Purchase") of 2,702,410 pounds natural uranium concentrate ("U3O8") for an aggregate purchase price of US$250 million based on the five day average UxC spot price.

Revenue Increased 26% Year-Over-Year to a Record $34.8 million Sixth Consecutive Quarter Reporting Positive Adjusted EBITDA KITS Virtual Try-On Reaches Milestone with Over 1.35 Million Glasses Tried On VANCOUVER, BC, May 8, 2024 /CNW/ - Kits Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), the leading vertically integrated eyecare provider, is reporting its results for the first quarter ended March 31, 2024.

WELL achieved record quarterly revenues of $231.6 million in Q1-2024, an increase of 37% as compared to Q1-2023 driven by acquisitions and organic growth of 13% which includes growth related to our clinic absorption program.WELL achieved Adjusted EBITDA(1) of $28.3 million in Q1-2024, an increase of 6% as compared to Q1-2023. WELL's Canadian business grew its Adjusted EBITDA in Q1- 2024 by 19% to $14.6 million on a YoY basis.WELL achieved Net Income of $19.6 million or $0.06 per share in Q1-2024 as compared to a loss of $10.6 million in Q1-2023 and Adjusted Net Income (1) of $20.2 million ...